Article
Gene replacement therapy for Lafora disease in the <i> Epm2a <sup>-/-</sup> </i> mouse model
2023-12-14
Abstract excerpt
Lafora disease is a rare and fatal form of progressive myoclonic epilepsy typically occurring early in adolescence. Common symptoms include seizures, dementia, and a progressive neurological decline leading to death within 5-15 years from onset. The disease results from mutations transmitted with autosomal recessive inheritance in the EPM2A gene, encoding laforin, a dual-specificity phosphatase, or the EPM2B gen...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 3c729cc0-a999-5115-8365-0762269cb6c1
- DOI
- 10.1101/2023.12.14.571636
